ACTRN12610000345088招募中2 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Schering-Plough0 个研究点目标入组 500 人开始时间: 2010年4月29日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 40 Years 至 75 Years（—）
- 性别
- All
入选标准
- •1. Has a diagnosis of clinically stable COPD (indicated by no exacerbations or changes in treatment within 6 weeks of screening.
- •2. Has a history for 3 months or more of sputum production most days of week.
- •3. Must be an ex-smoker with at least 6-months smoking cessation or a current smker with a smoking history of 10 or more pack-years.
排除标准
- •1. Has been diagnosed with asthma or other clinically relevant lung disease.
- •2. Has undergone a lobectomy, pneumonectomy, lung volume reduction or other lung surgery.
- •3. Needs supplemental oxygen therapy for more than 12 hours per day.
- •4. A low white cell count at the screening visit.
- •5. Subjects using medication that may interfere with the effect of the study medication or has a clinically relevant medical condition that interferes with study procedures/evaluations or any condition that is determined to be significant by the principal investigator.
研究者
相似试验
进行中（未招募）
1 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPDCOPDMedDRA version: 9.1 Level: LLT Classification code 10009033 Term: Chronic obstructive pulmonary diseaseEUCTR2008-003780-38-FRSchering-Plough Research Institute500
进行中（未招募）
1 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD - NDCOPDMedDRA version: 9.1 Level: PT Classification code 10009033EUCTR2008-003780-38-ITSchering Plough Research Institute500
进行中（未招募）
1 期
A Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPDCOPDMedDRA version: 9.1 Level: LLT Classification code 10009033 Term: Chronic obstructive pulmonary diseaseEUCTR2008-003780-38-GRSchering-Plough Research Institute500
已完成
不适用
Dose-ranging study of SCH34117 in the treatment of patients with seasonal allergic rhinitisSeasonal allergic rhinitisRespiratoryDiseases of upper respiratory tractISRCTN32042139Schering-Plough Research Institute (SPRI) (USA)1,026
进行中（未招募）
不适用
A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis.PsoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2006-006601-83-DKSchering-Plough Research Institute, a division of Schering Corp.30